![](/img/cover-not-exists.png)
PCN141 USE OF COST-EFFECTIVENESS AFFORDABILITY CURVES IN EVALUATING CANCER DRUGS IN ENGLAND
Yi, Y., Lucherini, S.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.337
Date:
November, 2019
File:
PDF, 381 KB
2019